Side effects and watch-outs
- Injection site reaction
- Mild fatigue
- Headache
- Generally well tolerated — no erythropoietic effects
- Limited long-term human data
Peptide / Neuroprotective
ARA-290 (Cibinetide)
Non-erythropoietic EPO analog targeting the innate repair receptor (IRR). Potent anti-inflammatory and neuroprotective. Phase 2/3 trials ongoing for neuropathic pain and sarcoidosis. Does NOT stimulate red blood cell production.
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.